Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda

BACKGROUND: High-risk human papillomavirus (hrHPV) may cause more than 99% of cervical cancers worldwide. Little is known about performance differences in tests for hrHPV. OBJECTIVE: This study analysed agreement for detection of hrHPV between the established, clinically validated Xpert HPV assay an...

Descripción completa

Detalles Bibliográficos
Autores principales: Murangwa, Anthere, Desai, Kanan T., Gage, Julia C., Murenzi, Gad, Tuyisenge, Patrick, Kanyabwisha, Faustin, Musafili, Aimable, Kubwimana, Gallican, Mutesa, Leon, Anastos, Kathryn, Kim, Hae-Young, Castle, Philip E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639372/
https://www.ncbi.nlm.nih.gov/pubmed/36353194
http://dx.doi.org/10.4102/ajlm.v11i1.1827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639372/
https://www.ncbi.nlm.nih.gov/pubmed/36353194
http://dx.doi.org/10.4102/ajlm.v11i1.1827

Ejemplares similares